TFF Pharmaceuticals: Not A Matter Of If, But When The Shares Will Run Much Higher

  • The company’s generic technology provides important benefits and is applicable in a wide range of situations. The company has two dozen shots at goal and is still adding.
  • Cash isn’t a problem for at least a year and revenues are likely to kick in well before that.
  • None of their TFF dry powder formulations has failed as of yet.
  • Learn More »